777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies

Sarah Whelan; Christopher Karim; Jordan Ye; Timothy Ingallinera; Ganesh Cherala; Katherine Jameson; Anja Williams; Adam Sharp; Matthew Krebs; Simon Pacey; Sarah Blagden; Ruth Plummer; Daniel Hochhauser; Jeff Evans; Johann Bono; Janine Powers

doi:10.1136/jitc-2022-SITC2022.0777

777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies

Sarah Whelan, Christopher Karim, Jordan Ye, Timothy Ingallinera, Ganesh Cherala, Katherine Jameson, Anja Williams, Adam Sharp, Matthew Krebs, Simon Pacey, Sarah Blagden, Ruth Plummer, Daniel Hochhauser, Jeff Evans, Johann Bono, Janine Powers

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Journal for ImmunoTherapy of Cancer
Volume	10
DOIs	https://doi.org/10.1136/jitc-2022-SITC2022.0777
Publication status	Published - 7 Nov 2022

Access to Document

10.1136/jitc-2022-SITC2022.0777

Cite this

Whelan, S., Karim, C., Ye, J., Ingallinera, T., Cherala, G., Jameson, K., Williams, A., Sharp, A., Krebs, M., Pacey, S., Blagden, S., Plummer, R., Hochhauser, D., Evans, J., Bono, J., & Powers, J. (2022). 777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies. Journal for ImmunoTherapy of Cancer, 10. https://doi.org/10.1136/jitc-2022-SITC2022.0777

@article{0d94a1d1ea0949679bba7d14a86e65db,

title = "777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies",

author = "Sarah Whelan and Christopher Karim and Jordan Ye and Timothy Ingallinera and Ganesh Cherala and Katherine Jameson and Anja Williams and Adam Sharp and Matthew Krebs and Simon Pacey and Sarah Blagden and Ruth Plummer and Daniel Hochhauser and Jeff Evans and Johann Bono and Janine Powers",

year = "2022",

month = nov,

day = "7",

doi = "10.1136/jitc-2022-SITC2022.0777",

language = "English",

volume = "10",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "Springer Nature",

}

Whelan, S, Karim, C, Ye, J, Ingallinera, T, Cherala, G, Jameson, K, Williams, A, Sharp, A, Krebs, M, Pacey, S, Blagden, S, Plummer, R, Hochhauser, D, Evans, J, Bono, J & Powers, J 2022, '777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies', Journal for ImmunoTherapy of Cancer, vol. 10. https://doi.org/10.1136/jitc-2022-SITC2022.0777

TY - JOUR

T1 - 777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies

AU - Whelan, Sarah

AU - Karim, Christopher

AU - Ye, Jordan

AU - Ingallinera, Timothy

AU - Cherala, Ganesh

AU - Jameson, Katherine

AU - Williams, Anja

AU - Sharp, Adam

AU - Krebs, Matthew

AU - Pacey, Simon

AU - Blagden, Sarah

AU - Plummer, Ruth

AU - Hochhauser, Daniel

AU - Evans, Jeff

AU - Bono, Johann

AU - Powers, Janine

PY - 2022/11/7

Y1 - 2022/11/7

U2 - 10.1136/jitc-2022-SITC2022.0777

DO - 10.1136/jitc-2022-SITC2022.0777

M3 - Meeting Abstract

SN - 2051-1426

VL - 10

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

ER -